RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
ALBANO F
Collezione AOU Città della Salute di Torino
Items : 32
Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy. in Haematologica / Haematologica. 2025 Mar 1;110(3):608-620. doi: 10.3324/haematol.2024.285448.
2025
AOU Città della Salute di Torino
AOU Novara
Huls G; Valent P; Eisfeld AK; Albano F; Visani G; DiBona E; Roti G; Rigolin GM; Marvalle D; Audisio E; Festuccia M; Venditti A; Forghieri F; Galimberti S; Lanza F; Pullarkat S; Lunghi M; Gotlib JR; Candoni A; Capelli D; Deeg HJ; Gurrieri C; Yeung CCS; Cairoli R; Morgan EA; Ferrara F; Marcucci G; Papayannidis C; Tecchio C; et alii...
Upfront intensive treatment analysis of the Italian Cohort Study on FLT3-mutated AML patients (FLAM): The impact of a FLT3 inhibitor addition to standard chemotherapy in the real-life setting. in Cancer / Cancer. 2025 Apr 1;131(7):e35824. doi: 10.1002/cncr.35824.
2025
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara
Marconi G; Petracci E; Valli I; Volpi R; Zamagni F; Mattei A; Ottaviani E; Bochicchio MT; Bocchia M; Todisco E; Cilloni D; Rigolin GM; Giannini MB; Bernardi M; Romani C; Fracchiolla N; Olivieri A; Albano F; Lunghi M; Cambò B; Candoni A; Scappini B; Chiusolo P; Audisio E; Martelli MP; Martinelli G; Mulè A; Papayannidis C; Azzali I; et alii...
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study. in Cancers / Cancers (Basel). 2024 Mar 20;16(6):1228. doi: 10.3390/cancers16061228.
2024
AOU Città della Salute di Torino
Mauro FR; Scalzulli PR; Scarfò L; Minoia C; Murru R; Sportoletti P; Frigeri F; Albano F; Di Renzo N; Sanna A; Laurenti L; Massaia M; Cassin R; Coscia M; Patti C; Pennese E; Tafuri A; Chiarenza A; Galieni P; Perbellini O; Selleri C; Califano C; Ferrara F; Cuneo A; Murineddu M; Palumbo G; Scortechini I; Tedeschi A; Trentin L; et alii...
Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study. in Hematological oncology / Hematol Oncol. 2024 Jan;42(1):e3216. doi: 10.1002/hon.3216. Epub 2023 Sep 29.
2024
AOU Città della Salute di Torino
AOU Novara
Malgieri S; Molica S; Iannella E; Gozzetti A; Reda G; Caira M; Finsinger P; Gualberti G; Zamprogna G; Coscia M; Albano F; Trentin L; Vallisa D; Pane F; Cuneo A; Mauro FR; Albi E; Chiarenza A; Gaidano G; Sportoletti P; Laurenti L;
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib. in Annals of hematology / Ann Hematol. 2024 Feb;103(2):427-436. doi: 10.1007/s00277-023-05556-0. Epub 2023 Nov 28.
2024
AOU Città della Salute di Torino
Caocci G; La Nasa G; Breccia M; Scalzulli E; Elena C; Giai V; Scaffidi L; Baratè C; Iezza M; Albano F; De Gregorio F; Cattaneo D; Trawinska MM; Loi M; Fozza C; Pregno P; Stagno F; Binotto G; Gozzini A; Orlandi EM; Annunziata M; Bonifacio M; Castagnetti F; Galimberti S; Attolico I; Iurlo A; Abruzzese E; Luciano L; Mulas O; et alii...
Efficacy and safety of nilotinib as frontline treatment in elderly (>?65 years) chronic myeloid leukemia patients outside clinical trials. in Annals of hematology / Ann Hematol. 2023 Jun;102(6):1375-1382. doi: 10.1007/s00277-023-05159-9. Epub 2023 Apr 20.
2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Castagnetti F; Iurlo A; Sica S; Iovine M; Dragani M; Pregno P; Palmieri R; Albano F; Sorà F; Galimberti S; Esposito MR; Bocchia M; Sica A; Martino B; Tiribelli M; Annunziata M; Latagliata R; Gugliotta G; Luciano L; Rosti G; Breccia M;
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study. in Haematologica / Haematologica. 2023 Aug 1;108(8):2091-2100. doi: 10.3324/haematol.2022.282116.
2023
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara
Foà R; Nanni M; Del Giudice I; Guarini A; Fazi P; Vignetti M; Piciocchi A; Cuneo A; Neri A; De Novi LA; De Propris MS; Pietrasanta D; Mattiello V; Visentin A; Vitale C; Albano F; Molinari MC; Liberati AM; Giordano A; Gottardi D; Galieni P; Patrizi VB; Tani M; Arcari A; Musuraca G; Deodato M; Massaia M; Rigolin GM; Scarfò L; et alii...
Incidence of blast phase in myelofibrosis according to anemia severity. in EJHaem / EJHaem. 2023 Jul 17;4(3):679-689. doi: 10.1002/jha2.745. eCollection 2023 Aug.
2023
AOU Città della Salute di Torino
Barbui T; Borsani O; Devos T; Ross DM; Benevolo G; Silver RT; Albano F; Gotlib J; Polverelli N; Elli EM; Kiladjian JJ; De Stefano V; Iurlo A; Palandri F; Kuykendall A; Caramella M; Guglielmelli P; Rumi E; Mora B; Maffioli M; Porta MGD; Bertù L; Komrokji R; Vannucchi AM; Passamonti F;
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients. in Leukemia / Leukemia. 2022 Oct;36(10):2453-2460. doi: 10.1038/s41375-022-01673-3. Epub 2022 Aug 30.
2022
AOU Città della Salute di Torino
Mora B; Guglielmelli P; Kuykendall A; Rumi E; Maffioli M; Palandri F; De Stefano V; Caramella M; Salmoiraghi S; Kiladjian JJ; Gotlib J; Iurlo A; Cervantes F; Ruggeri M; Silver RT; Albano F; Benevolo G; Ross DM; Della Porta MG; Devos T; Rotunno G; Komrokji RS; Casetti IC; Merli M; Brociner M; Caramazza D; Auteri G; Barbui T; Cattaneo D; et alii...
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study. in Haematologica / Haematologica. 2022 Jun 1;107(6):1470-1473. doi: 10.3324/haematol.2021.280325.
2022
AOU Città della Salute di Torino
AOU Novara
Pompili M; Trentin L; Tedeschi A; Mauro FR; Scarfò L; Del Poeta G; Autore F; Tomasso A; Arena V; Di Sevo D; Rughini A; Piciocchi A; Frustaci AM; Ielo C; Deodato M; Cassin R; Albano F; Quaglia FM; Pennese E; Gentile M; Murru R; Moia R; Motta M; Coscia M; Visentin A; Innocenti I; Reda G; Foà R; Ghia P; et alii...
BCR-ABL1 compound mutants: prevalence, spectrum and correlation with tyrosine kinase inhibitor resistance in a consecutive series of Philadelphia chromosome-positive leukemia patients analyzed by NGS. in Leukemia / Leukemia. 2021 Jul;35(7):2102-2107. doi: 10.1038/s41375-020-01098-w. Epub 2020 Dec 1.
2021
AOU Città della Salute di Torino
Percesepe A; Rosti G; Papayannidis C; Gugliotta G; Castagnetti F; Capodanno I; D'Adda M; Crugnola M; Albano F; Lunghi F; Galimberti S; Pregno P; Bonifacio M; Iurlo A; Sorà F; Sica S; De Benedittis C; Bavaro L; Martelli M; Soverini S; Mignone F; Baccarani M; Martinelli G; Cavo M;
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib. in Annals of hematology / Ann Hematol. 2021 Aug;100(8):2005-2014. doi: 10.1007/s00277-020-04392-w. Epub 2021 Jan 3.
2021
AOU Città della Salute di Torino
Cattaneo D; Sicuranza A; Trawinska MM; Pirillo F; Gugliotta G; Stella R; De Gregorio F; Baratè C; Scaffidi L; Simula MP; Efficace F; Luzi D; Fozza C; Albano F; Gozzini A; Bocchia M; Stagno F; Abruzzese E; Pregno P; Binotto G; Castagnetti F; Martino B; Luciano L; Tiribelli M; Galimberti S; Annunziata M; Bonifacio M; Capodanno I; Mulas O; et alii...
Prognostic Factors for Overall Survival In Chronic Myeloid Leukemia Patients: A Multicentric Cohort Study by the Italian CML GIMEMA Network. in Frontiers in oncology / Front Oncol. 2021 Aug 26;11:739171. doi: 10.3389/fonc.2021.739171. eCollection 2021.
2021
AOU Città della Salute di Torino
Rosti G; Saccona F; Mulas O; Levato L; Guella A; Pietrantuono G; La Barba G; Miggiano MC; Abruzzese E; Giai V; De Candia MS; Sanpaolo G; Maggi A; DiTonno P; Reddiconto G; Binotto G; Bocchia M; Galimberti S; Sorà F; Rege-Cambrin G; Fava C; Patriarca A; Capodanno I; Bergamaschi M; Albano F; Scortechini AR; Gozzini A; Pizzuti M; Luciano L; et alii...
Favorable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib. in Hematological oncology / Hematol Oncol. 2020 Oct;38(4):607-610. doi: 10.1002/hon.2765. Epub 2020 Jul 23.
2020
AOU Città della Salute di Torino
Mulas O; Caocci G; Annunziata M; Martino B; Luciano L; Castagnetti F; Pregno P; Galimberti S; Albano F; Orlandi EM; Sgherza N; Iurlo A; Bonifacio M; Binotto G; Gozzini A; Bocchia M; Abruzzese E; Fozza C; Simula MP; De Gregorio F; Gugliotta G; Pirillo F; Baratè C; Attolico I; Elena C; Cattaneo D; Scaffidi L; Sicuranza A; Trawinska MM; et alii...
High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2). in Haematologica / Haematologica. 2020 Nov 1;105(11):2671-2674. doi: 10.3324/haematol.2019.235705.
2020
AOU Alessandria
AOU Città della Salute di Torino
Della Starza I; Del Giudice I; Cuneo A; Albano F; Neri A; Vignetti M; Piciocchi A; Nanni M; Musolino C; Del Poeta G; Battistini R; Gozzetti A; Pietrasanta D; Reda G; Tedeschi A; Liberati AM; Re F; Angelucci E; Zaja F; Coscia M; Ilariucci F; Soddu S; Molica S; Mauro FR; De Propris MS; Raponi S; Guarini AR; Foà R;
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial. in Leukemia / Leukemia. 2020 Mar;34(3):914-918. doi: 10.1038/s41375-019-0589-3. Epub 2019 Oct 14.
2020
AOU Città della Salute di Torino
Fabbiano F; Di Renzo N; Cortelezzi A; Maria D'Arco A; Fozza C; Frairia C; Link H; Schmitz N; Rollig C; Hanel M; Brandts CH; Lubbert M; Wattad M; Annibali O; Salih HR; Hertenstein B; Fiedler W; Brossart P; La Nasa G; Melillo L; Rambaldi A; Cairoli R; Borlenghi E; Breccia M; Sborgia M; Di Bona E; Efficace F; Albano F; Divona M; et alii...
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study. in Blood cancer journal / Blood Cancer J. 2020 Jun 8;10(6):66. doi: 10.1038/s41408-020-0333-2.
2020
AOU Città della Salute di Torino
Caocci G; Mulas O; Capodanno I; Abruzzese E; Iurlo A; Luciano L; Albano F; Annunziata M; Tiribelli M; Bonifacio M; Galimberti S; Castagnetti F; Sgherza N; Stagno F; Gozzini A; Orlandi EM; Luzi D; Binotto G; Pregno P; Fozza C; Efficace F; Simula MP; Trawinska MM; Cattaneo D; De Gregorio F; Attolico I; Stella R; Scaffidi L; Baratè C; et alii...
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors. in Annals of hematology / Ann Hematol. 2020 Jul;99(7):1525-1530. doi: 10.1007/s00277-020-04102-6. Epub 2020 May 30.
2020
AOU Città della Salute di Torino
Mulas O; Caocci G; Stagno F; Bonifacio M; Annunziata M; Luciano L; Orlandi EM; Abruzzese E; Sgherza N; Martino B; Albano F; Galimberti S; Pregno P; Bocchia M; Castagnetti F; Tiribelli M; Binotto G; Gozzini A; Capodanno I; Fozza C; Luzi D; Efficace F; Simula MP; Scaffidi L; De Gregorio F; Elena C; Trawinska MM; Cattaneo D; Attolico I; et alii...
Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group. in American journal of hematology / Am J Hematol. 2020 Jan;95(1):E1-E3. doi: 10.1002/ajh.25644. Epub 2019 Nov 1.
2020
AOU Città della Salute di Torino
Agnoli S; Siracusa C; Accetta R; Uccella S; Cavalloni C; Benevolo G; Albano F; Silver RT; Ruggeri M; De Stefano V; Palandri F; Devos T; Iurlo A; Cervantes F; Gotlib J; Kiladjian JJ; Komrokji RS; Caramella M; Rambaldi A; Barraco D; Maffioli M; Rumi E; Guglielmelli P; Mora B; Merli M; Barbui T; Bertù L; Cazzola M; Vannucchi AM; et alii...
Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second- and third-generation tyrosine kinase inhibitors. in International journal of cardiology / Int J Cardiol. 2020 Feb 15;301:163-166. doi: 10.1016/j.ijcard.2019.10.036. Epub 2019 Oct 24.
2020
AOU Città della Salute di Torino
Gugliotta G; Pirillo F; Cattaneo D; Baratè C; Attolico I; Elena C; Scaffidi L; Trawinska MM; De Gregorio F; Simula MP; Stagno F; Fozza C; Bocchia M; Gozzini A; Castagnetti F; Binotto G; Martino B; Sgherza N; Pregno P; Iurlo A; Galimberti S; Albano F; Orlandi EM; Bonifacio M; Abruzzese E; Luciano L; Mulas O; Annunziata M; Caocci G; et alii...
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP. in Blood advances / Blood Adv. 2019 Dec 23;3(24):4280-4290. doi: 10.1182/bloodadvances.2019000865.
2019
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara
Soverini S; Vigneri P; Rosti G; Russo D; Saglio G; Castagnetti F; Pane F; Breccia M; Bonifacio M; Tomassetti S; Trabacchi E; Spadano R; Tiribelli M; Stagno F; Sancetta R; Sica S; Rege-Cambrin G; Rupoli S; Salvucci M; Rapezzi D; Pregno P; Palmieri F; Musolino C; Miggiano MC; Montefusco E; Melpignano A; Martino B; Marasca R; Lunghi M; et alii...
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO). in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation / Biol Blood Marrow Transplant. 2019 Dec;25(12):2388-2397. doi: 10.1016/j.bbmt.2019.07.037. Epub 2019
2019
AOU Città della Salute di Torino
Candoni A; Rambaldi A; Fanin R; Velardi A; Arcese W; Ciceri F; Lazzarotto D; Lussana F; Olivieri J; Grillo G; Parma M; Bruno B; Sora F; Bernasconi P; Saccardi R; Foà R; Sessa M; Bresciani P; Giglio F; Picardi A; Busca A; Sica S; Perruccio K; Zucchetti E; Diral E; Iori AP; Colombo AA; Tringali S; Santarone S; et alii...
Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention. in International journal of cardiology / Int J Cardiol. 2019 Aug 1;288:124-127. doi: 10.1016/j.ijcard.2019.04.051. Epub 2019 Apr 17.
2019
AOU Città della Salute di Torino
Cattaneo D; Elena C; Baratè C; Trawinska MM; Scaffidi L; Fozza C; Martino B; Albano F; Pregno P; Binotto G; Stagno F; Gozzini A; Castagnetti F; Luciano L; Annunziata M; Iurlo A; Orlandi EM; Galimberti S; Abruzzese E; Bonifacio M; Mulas O; Caocci G; Scalzulli E; La Nasa G; Foà R; Breccia M;
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart. in Hematological oncology / Hematol Oncol. 2019 Aug;37(3):296-302. doi: 10.1002/hon.2606. Epub 2019 Apr 17.
2019
AOU Città della Salute di Torino
Scaffidi L; Baratè C; Gugliotta G; Albano F; De Gregorio F; Cattaneo D; Trawinska MM; Fozza C; Pregno P; Binotto G; Stagno F; Orlandi EM; Gozzini A; Annunziata M; Bonifacio M; Sgherza N; Galimberti S; Castagnetti F; Attolico I; Iurlo A; Luciano L; Abruzzese E; Mulas O; Caocci G; Elena C; Pirillo F; Scalzulli E; La Nasa G; Foà R; et alii...
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project. in Blood cancer journal / Blood Cancer J. 2018 Sep 21;8(10):89. doi: 10.1038/s41408-018-0128-x.
2018
AOU Città della Salute di Torino
Barraco D; Mora B; Guglielmelli P; Rumi E; Maffioli M; Rambaldi A; Caramella M; Komrokji R; Gotlib J; Kiladjian JJ; Cervantes F; Devos T; Palandri F; De Stefano V; Ruggeri M; Silver RT; Benevolo G; Albano F; Merli M; Pietra D; Barbui T; Rotunno G; Cazzola M; Giorgino T; Vannucchi AM; Passamonti F; Barraco D; Mora B; Guglielmelli P; et alii...
Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia. in Haematologica / Haematologica. 2017 Sep;102(9):1530-1536. doi: 10.3324/haematol.2017.169532. Epub 2017 Jun 1.
2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Martinelli G; Cavo M; Foà R; Soverini S; Caracciolo C; Bonifacio M; Binotto G; Bigazzi C; Tiribelli M; Sorà F; La Barba G; Martino B; Stagno F; Cavazzini F; D'Adda M; Pregno P; Levato L; Intermesoli T; Abruzzese E; Albano F; Iurlo A; Breccia M; Castagnetti F; Gugliotta G; Pane F; Saglio G; Baccarani M; Rosti G; Gugliotta G; et alii...
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2017 Feb 20;35(6):605-612. doi: 10.1200/JCO.2016.67.1982. Epub 2016 Oct 31.
2017
AOU Città della Salute di Torino
Lo-Coco F; Schlenk RF; Ehninger G; Mandelli F; Amadori S; Döhner H; Ganser A; Döhner K; Fabbiano F; Cortelezzi A; Di Renzo N; D'Arco AM; Fozza C; Pogliani EM; Frairia C; Link H; Schmitz N; Röllig C; Hänel M; Brandts CH; Lübbert M; Wattad M; Salih HR; Hertenstein B; Brossart P; Fiedler W; La Nasa G; Melillo L; Rambaldi A; et alii...
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis. in Leukemia / Leukemia. 2017 Dec;31(12):2726-2731. doi: 10.1038/leu.2017.169. Epub 2017 May 31.
2017
AOU Città della Salute di Torino
Passamonti F; Giorgino T; Mora B; Guglielmelli P; Rumi E; Maffioli M; Rambaldi A; Caramella M; Komrokji R; Gotlib J; Kiladjian JJ; Cervantes F; Devos T; Palandri F; De Stefano V; Ruggeri M; Silver RT; Benevolo G; Albano F; Caramazza D; Merli M; Pietra D; Casalone R; Rotunno G; Barbui T; Cazzola M; Vannucchi AM; Passamonti F; Giorgino T; et alii...
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib. in American journal of hematology / Am J Hematol. 2017 Aug;92(8):797-805. doi: 10.1002/ajh.24774. Epub 2017 May 30.
2017
AO Ordine Mauriziano
AOU Città della Salute di Torino
Giovanni M; Cavo M; Bochicchio MT; Soverini S; Bocchia M; Gherlinzoni F; Fava C; Bonifacio M; Sica S; Tiribelli M; Usala E; Annunziata M; Pregno P; Orlandi E; Martino B; Cavazzini F; Rossi G; Rupoli S; Vigneri P; Abruzzese E; Albano F; Iurlo A; Levato L; Breccia M; Gugliotta G; Castagnetti F; Saglio G; Pane F; Baccarani M; et alii...
Concentrations of polychlorinated dibenzodioxins, polychlorodibenzofurans, and polychlorobiphenyls in women of reproductive age in Italy: A human biomonitoring study. in International journal of hygiene and environmental health / Int J Hyg Environ Health. 2017 Apr;220(2 Pt B):378-386. doi: 10.1016/j.ijheh.2016.11.009. Epub 2016
2017
AOU Città della Salute di Torino
Pirola F; Porpora MG; Marra V; Maneschi F; Maiorana A; Iamiceli AL; Iacovella N; Giambanco L; Fulgenzi AR; Franchini S; De Luca S; Corvetti R; Conversano M; Carraro V; Battista T; Albano FL; Abballe A; Abate V; Ingelido AM; Procopio E; Suma N; Valentini S; Valsenti L; Vecchiè V; De Felip E;
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib. in Leukemia / Leukemia. 2015 Sep;29(9):1823-31. doi: 10.1038/leu.2015.152. Epub 2015 Jun 19.
2015
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Pane F; Martinelli G; Cavo M; Alimena G; Testoni N; Soverini S; Venturi C; Leoni P; Cavazzini F; Rossi G; Gherlinzoni F; Pregno P; Levato L; Intermesoli T; Martino B; Albano F; Abruzzese E; Iurlo A; Stagno F; Breccia M; Gugliotta G; Castagnetti F; Saglio G; Rosti G; Baccarani M;
Current exposure of Italian women of reproductive age to PFOS and PFOA: A human biomonitoring study. in Chemosphere / Chemosphere. 2015 Oct;137:1-8. doi: 10.1016/j.chemosphere.2015.03.046. Epub 2015 May 15.
2015
AOU Città della Salute di Torino
De Felip E; Abballe A; Albano FL; Battista T; Carraro V; Conversano M; Franchini S; Giambanco L; Iacovella N; Ingelido AM; Maiorana A; Maneschi F; Marra V; Mercurio A; Nale R; Nucci B; Panella V; Pirola F; Porpora MG; Procopio E; Suma N; Valentini S; Valsenti L; Vecchiè V;